| Drug Name | Motexafin gadolinium |
|---|---|
| Other Drug Names | Xcytrin; PCI-0120; gadolinium texaphyrin; Gd texaphyrin; Gd-Tex; FP-GP1; API-GP3 |
| Chemical Name | [PB-7-11-233'2'4]-Bis[acetato-Κo][9,10-diethyl-20,21-bis[2-[2-[2-methoxy-ethoxy]ethoxy]ethoxy]-4,15-dimethyl-8,11-imino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine-5,14-dipropanolato-Κn1,Κn18,Κn23,Κn24,Κn25]-gadolinium hydrate |
| Formula | C52H72GdN5O12.xH2O,x=0～2 |
| Mol. Wt. | 1148.4 (anhydrous) |
| CAS No. | 156436-89-4 |
| UNII | 6433A42F4F |
| Target-based Actions | Thioredoxin reductase modulator |
| ATC Codes | L01X |
| Originator Company | Pharmacyclics, Inc. |
| Structure |
 |
Extended Information